The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNPSN.L Regulatory News (NPSN)

  • There is currently no data for NPSN

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

18 Sep 2019 16:30

RNS Number : 8496M
Naspers Limited
18 September 2019
 

Naspers Limited

(Incorporated in the Republic of South Africa)

(Registration number 1925/001431/06)

JSE share code: NPN ISIN: ZAE000015889

LSE ADS code: NPSN ISIN: US 6315121003

("Naspers" or "the company")

 

DEALING IN SECURITIES BY DIRECTOR

 

In compliance with rules 3.63 to 3.74 of the JSE Limited Listings Requirements, the following information is disclosed:

Director: Steve Pacak

Company: Naspers Limited

Transaction date: 16 September 2019

 

Nature of transaction: On market sale of Naspers N shares

Number of shares: 180 000 Naspers N ordinary shares

Class of shares: N ordinary shares

Total value of transaction: R454 517 603.96

Volume weighted average

price per share: R2 525.0978

Highest price per share: R2 527.90

Lowest price per share: R2 505.99

 

Nature of transaction: Off market purchase of securities

Number of shares: 20 000 Naspers shares

Class of shares: N ordinary

Price per share: R2 544.94

Total value of transaction: R50 898 800.00

 

Date of vesting in the group

share-based incentive plan: The trades relate to offers of Naspers N ordinary share options made and accepted on 27 February 2009 in the MIH Services FZ LLC Share Trust (the Trust). The options vested in three equal tranches. The first tranche, 66 666 share options, vested on 27 February 2012, the second tranche, 66 667 share options vested on 27 February 2013 and the final tranche, 66 667 share options, vested on 27 February 2014.

 

In terms of the rules of the Trust the exercise of options and delivery of shares acquired may not be taken later than the tenth anniversary of the offer date, unless, as provided for in the Trust deed, the last date to exercise has been extended as a result of trade embargoes having been applied to a participant(s). In the case of Mr Pacak, the date was extended to 20 September 2019.  

On 16 September 2019 a total of 180 000 Naspers N ordinary shares were sold by Mr Pacak and 20 000 Naspers N ordinary shares, 200 000 Prosus N.V. N ordinary shares and 200 000 MultiChoice Group Limited ordinary shares will be delivered to Mr Pacak upon payment of the amount of R30 378 633.89 (being the listed market value on the date of the offers) from the proceeds of the sale of the 180 000 Naspers N ordinary shares (distributed to Mr Pacak), to settle the amount due to the Trust.

 

Nature of transaction: Sale of 180 000 vested Naspers N ordinary shares from the Naspers Share Incentive Scheme Trust and delivery of 20 000 Naspers N ordinary shares, 200 000 Prosus N.V. N ordinary shares and 200 000 MultiChoice Group Limited ordinary shares vested shares held in the Trust by Mr Pacak.

 

Additional disclosure: Exercised 200 000 Naspers options, 200 000 Prosus N.V. shares and 200 000 MultiChoice Group Limited shares and the full net gain after tax (excluding a cash balance due to Mr Pacak) on the disposal of 180 000 Naspers N ordinary shares was reinvested in Naspers N ordinary shares, Prosus N.V. ordinary shares and MultiChoice Group Limited shares resulting in the acquisition of 20 000 Naspers N ordinary shares, 200 000 Prosus N.V. N ordinary shares and 200 000 MultiChoice Group Limited ordinary shares.

 

The intention that is that these shares will be transferred to Mr Pacak's family trust resulting in an indirect, beneficial interest.

 

Nature of interest: Direct Beneficial

Clearance: Clearance has been received in terms of paragraph 3.66 of the JSE Listings Requirements

 

 

CAPE TOWN

18 September 2019

Sponsor: Investec Bank Limited

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHUWRSRKNAKAAR
Date   Source Headline
13th Jan 20229:30 amRNSIssue of Debt
11th Jan 20223:15 pmRNSTransaction in Own Shares
7th Jan 20227:00 amRNSDirector/PDMR Shareholding
4th Jan 20223:15 pmRNSTransaction in Own Shares
29th Dec 20217:00 amRNSTransaction in Own Shares
21st Dec 20213:15 pmRNSTransaction in Own Shares
20th Dec 20217:00 amRNSDirectorate Change
20th Dec 20217:00 amRNSDirectorate Change
14th Dec 20213:15 pmRNSTransaction in Own Shares
13th Dec 20213:15 pmRNSNotice of Intention to Delist ADSs from the LSE
7th Dec 20213:15 pmRNSTransaction in Own Shares
30th Nov 20213:15 pmRNSTransaction in Own Shares
25th Nov 20213:30 pmRNSTreasury Stock
23rd Nov 20213:15 pmRNSTransaction in Own Shares
22nd Nov 20217:00 amRNSHalf-year Report
22nd Nov 20217:00 amRNSHalf-year Report
16th Nov 20213:15 pmRNSTransaction in Own Shares
16th Nov 20217:00 amRNSTrading Statement
16th Nov 20217:00 amRNSTrading Statement
9th Nov 20213:15 pmRNSTransaction in Own Shares
2nd Nov 20213:15 pmRNSTransaction in Own Shares
26th Oct 20214:15 pmRNSTransaction in Own Shares
22nd Oct 20211:30 pmRNSClarificatory statement re dividend
21st Oct 20217:50 amRNSClarificatory statement re dividend
19th Oct 20214:15 pmRNSTransaction in Own Shares
12th Oct 20214:15 pmRNSTransaction in Own Shares
5th Oct 20214:15 pmRNSTransaction in Own Shares
4th Oct 20214:50 pmRNSStatement re Delivery Hero transaction
4th Oct 20214:50 pmRNSStatement re Delivery Hero transaction
1st Oct 20217:45 amRNSDirector/PDMR Shareholding
28th Sep 20214:15 pmRNSTransaction in Own Shares
21st Sep 20214:15 pmRNSTransaction in Own Shares
14th Sep 20214:30 pmRNSTransaction in Own Shares
7th Sep 20214:50 pmRNSTransaction in Own Shares
31st Aug 20214:50 pmRNSTransaction in Own Shares
31st Aug 20214:30 pmRNSDirector/PDMR Shareholding
31st Aug 20219:15 amRNSProsus increases stake in Delivery Hero
31st Aug 20219:15 amRNSProsus increases stake in Delivery Hero
31st Aug 20217:00 amRNSacquisition of 100% OF THE equity IN BillDesk
31st Aug 20217:00 amRNSacquisition of 100% OF THE equity IN BillDesk
26th Aug 20214:30 pmRNSDirectorate Change
26th Aug 20214:30 pmRNSDirectorate Change
25th Aug 20214:50 pmRNSAGM Statement
24th Aug 20214:50 pmRNSRESULTS OF ANNUAL GENERAL MEETING
23rd Aug 20217:30 amRNSProsus Share Repurchase Programme
23rd Aug 20217:30 amRNSShare Repurchase Programme
20th Aug 20214:45 pmRNSDirector/PDMR Shareholding
20th Aug 20214:45 pmRNSDirector/PDMR Shareholding
16th Aug 20217:00 amRNSSettlement Exchange Offer – AFM Notifications
16th Aug 20217:00 amRNSCapital Restructure and Exchange Offer Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.